Home » Topics » Regulatory

Regulatory
RSS

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

American Biogenetic Sciences' blood clot diagnostic test cleared for marketing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...